Все категории
| Product Name | Описание | Action |
|---|---|---|
| Деносумаб | Trade Name : Prolia Target : RANK ligand Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 3360(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with ... |
|
| Инфликсимаб | Trade Name : Remicade Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 4100 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Пембролизумаб, Keytruda, PD-1, Ламбролизумаб, MK-3475, SCH 900475, Моноклональные антитела, CAS No.1374853-91-4 | Trade Name : Keytruda Target : PD-1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 30990 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Бевацизумаб, Авастин, VEGF, Анти- VEGF моноклональное антитело, Анти- VEGF моноклональное антитело, Гуманизированное IgG1 антитело, Онкология биологическая / Антиангиогенная терапия, CAS No 216974-75-3 | Trade Name : Avastin Target : VEGF Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Ведолизумаб, Энтивио, MLN0002, Антиинтегриновый биологический, гуманизированный IgG1 моноклональный антитело, терапевтический ИБД / язвенный колит биологический / болезнь Крона биологический, CAS No.943609-66-3 | Trade Name : Entyvio Target : N/A Molecular Type : N/A Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Имиглюцераза,Cerezyme,rGCR,GBA (β- глюкоцереброзидная азе),Гликопротеин (это белок, содержащий 497 аминокислот, полученный с использованием технологии рекомбинантной ДНК), CAS No 154248-97-2 | Trade Name : Cerezyme® Target : GBA (β- glucocerebrosid ase) Molecular Type : Glycoprotein (This is a protein containing 497 amino acids, produced using recombinant DNA technology) Sales in 2025 (Millions of USD) : 1105(estimate) All detailed product information shall be subject to the issued final ... |
|
| Луспатерцепт-аамт, Реблозил, ACE-536, Рекомбинантный синтетический белок, Активин-рецепторная ловушка, Лиганды сверхсемейства трансформирующего фактора роста-β (TGF-β), Рекомбинантный синтетический белок | Trade Name : Reblozyl Target : Transforming growth factor-β (TGF- β)superfamily ligands Molecular Type : Recombinant Fusion Protein Sales in 2025 (Millions of USD) : 2000 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for ... |
|
| Relatlimab, Opdualag, BMS-986016, Ингибитор иммунного контрольного пункта Anti-LAG-3, Лимфоцитно- активационный ген-3 (LAG-3), Гуманизированный иммуноглобулин G4 (IgG4) Моноклональное антитело, CAS No. 1673516-98-7 | Trade Name : Opdualag Target : Lymphocyte- activation gene- 3 (LAG-3) Molecular Type : Humanized Immunoglobulin G4 (IgG4) Monoclonal Antibody Sales in 2025 (Millions of USD) : 1358 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentati... |
